Alexandra C. Walls - Concepedia

Author

Alexandra C. Walls

Also Known As

A.C. Walls, Alexandra C Walls, Alexandra C. Walls, Alexandra Walls, Baric, Ralph, Walls, Alexandra C., Willoughby, Isabelle

135

Publications

36.1K

Citations

H-Index

Concepts

All Affiliations

University of Washington Howard Hughes Medical Institute Vir Biotechnology (Switzerland)VIR Biotechnology (United States)Fred Hutch Cancer Center

About

Alexandra C. Walls is an author at University of Washington specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	39	49	26.2K
2	Natural Sciences	5	5	965
3	Engineering	4	4	269
4	Social Sciences	1	1	137
5	Allergy	1	1	195

Alexandra C. Walls

Publications

35.9K

Citations

H-Index

Page 1

	Year	Citations
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein Alexandra C. Walls, Young‐Jun Park, M. Alejandra Tortorici, Cell Virus StructureSars-cov-2 Spike GlycoproteinViral PathogenesisGlycobiologyImmunology	2020	9K
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding Tyler N. Starr, Allison J. Greaney, Sarah K. Hilton, Cell Viral DiagnosticsViral PathogenesisImmunologyMolecular BiologyViral Structural Protein	2020	2.2K
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody Dora Pinto, Young‐Jun Park, Martina Beltramello, Nature Vaccine TargetImmunologyAntibody EngineeringMedicineCovid-19	2020	2.1K
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology Luca Piccoli, Young‐Jun Park, M. Alejandra Tortorici, Cell Structure-guided High-resolution SerologyVirus StructureImmunodominant SitesImmunologyReceptor (Biochemistry)	2020	1.6K
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein Alexandra C. Walls, Young‐Jun Park, M. Alejandra Tortorici, Cell Virus StructureSars-cov-2 Spike GlycoproteinViral PathogenesisGlycobiologyImmunology	2020	1.5K
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift Elisabetta Cameroni, John E. Bowen, Laura E. Rosen, Nature VaccinationNeutralizing AntibodiesVaccine TargetHumoral ResponseImmunology	2021	1.2K
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity Bo Meng, Adam Abdullahi, Isabella A.T.M. Ferreira, Nature	2022	1.1K
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2 Matthew McCallum, Anna De Marco, Florian A. Lempp, Cell Viral PathogenesisImmunologyVirologyViral Structural ProteinMedicine	2021	998
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein Alexandra C. Walls, Young‐Jun Park, Marcello Tortorici, Coronavirus SpikeSars-cov-2 Spike GlycoproteinVirus StructureViral EvolutionGlycoprotein Trimers	2020	761
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies Dami A. Collier, Anna De Marco, Isabella A.T.M. Ferreira, Nature VaccinationVaccine DevelopmentImmunologyVirologySars-cov-2 B.1.1.7	2021	711

Page 1